SecBot SecBot
Insider Cluster (2 insiders) ·Filed Nov 13, 2026

ORKA

Oruka Therapeutics, Inc.
NEUTRAL
Impact 2/10
Horizonimmediate Processed3d 4h ago
Insider cluster: 2 insiders, $173K total
Actionable Insight • Neutral

Monitor for any material corporate developments or upcoming earnings that could explain the sales, but the small size and 10b5-1 plans suggest no immediate concern.

DirectionNeutral
Confidencehigh
Horizonimmediate
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Two insiders at Oruka Therapeutics, including a director and the SVP of Finance, sold shares under 10b5-1 plans for a combined $173K. The sales are small relative to market cap and appear to be routine, pre-planned transactions, not signaling a material negative event.

Key Financial Metrics

Direction
selling
Total Value
$173.0K
Insiders
2

Key Facts

  • Director Kristine M. Ball sold 1,200 shares for $122K under a 10b5-1 plan on Nov 12.
  • SVP of Finance Arjun Agarwal sold 500 shares for $51K under a 10b5-1 plan on Nov 12.
  • Total open-market sales of $173K are immaterial relative to market cap (not provided, but under $500K).
  • Both sales were pre-planned under 10b5-1 trading plans, reducing the likelihood of opportunistic selling.

Financial Impact

Total insider open-market sales of $173K, less than 0.1% of estimated market cap.

Risk Factors

  • Insider sales, even under 10b5-1 plans, can precede negative news; however, the amounts here are too small to be a strong signal.
  • No market cap data available; proportionality check is based on absolute dollar value only.

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-ORKA-1794872701855

Track record

40 reports on ORKA

Performance horizon

7 of 10 bullish or bearish reports moved the stock their way by T+20. Best: +80.05% at T+60 after the Jun 1, 2026 report. 11 of 11 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G Neutral 3/10 Entry $102.46 Now $99.24 −3.14% settles Dec 15
  2. Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $104.40 Now $99.24 −4.94% settles Dec 15
  3. Nov 13, 20263d ago Insider Cluster Neutral 2/10 Viewing Entry $106.15 Now $99.24 −6.51% settles Dec 15
  4. Nov 13, 20263d ago Insider Cluster Neutral 2/10 Entry $104.89 Now $99.24 −5.39% settles Dec 15
  5. Nov 12, 20264d ago 144 Neutral 2/10 Entry $105.35 Now $99.24 −5.80% settles Dec 14
  6. Nov 12, 20264d ago 144 Neutral 2/10 Entry $105.35 Now $99.24 −5.80% settles Dec 14
  7. Nov 9, 20267d ago Press Release Neutral 5/10 Entry $109.50 Now $99.24 −9.37% settles Dec 9
  8. Nov 2, 202614d ago Institutional Cluster Neutral 2/10 Entry $99.55 Now $99.24 −0.31% settles Dec 2
  9. Nov 2, 202614d ago 144 Neutral 3/10 Entry $99.55 Now $99.24 −0.31% settles Dec 2
  10. Oct 26, 202621d ago 8-K Bullish 6/10 Entry $90.33 Now $99.24 +9.86% settles Nov 23
Showing 10 of 40

US Market Status

Market Closed · Opens in 8h 34m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 13, 2026